These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22160140)

  • 1. Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells.
    Shin H; Lee YS; Lee YC
    Oncol Rep; 2012 Apr; 27(4):1111-5. PubMed ID: 22160140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium butyrate-induced death-associated protein kinase expression promote Raji cell morphological change and apoptosis by reducing FAK protein levels.
    Zhang HT; Feng ZL; Wu J; Wang YJ; Guo X; Liang NC; Zhu ZY; Ma JQ
    Acta Pharmacol Sin; 2007 Nov; 28(11):1783-90. PubMed ID: 17959029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.
    Condorelli F; Gnemmi I; Vallario A; Genazzani AA; Canonico PL
    Br J Pharmacol; 2008 Feb; 153(4):657-68. PubMed ID: 18059320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions.
    Gandesiri M; Chakilam S; Ivanovska J; Benderska N; Ocker M; Di Fazio P; Feoktistova M; Gali-Muhtasib H; Rave-Fränk M; Prante O; Christiansen H; Leverkus M; Hartmann A; Schneider-Stock R
    Apoptosis; 2012 Dec; 17(12):1300-15. PubMed ID: 23011180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
    Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
    Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor.
    Wakabayashi K; Saito H; Kaneko F; Nakamoto N; Tada S; Hibi T
    Int J Oncol; 2005 Jan; 26(1):233-9. PubMed ID: 15586245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression.
    Saito H; Ebinuma H; Takahashi M; Kaneko F; Wakabayashi K; Nakamura M; Ishii H
    Hepatology; 1998 May; 27(5):1233-40. PubMed ID: 9581676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells.
    Zhao X; Yang W; Shi C; Ma W; Liu J; Wang Y; Jiang G
    Tumour Biol; 2011 Apr; 32(2):335-46. PubMed ID: 21113745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in human gastric cancer by sodium butyrate.
    Litvak DA; Hwang KO; Evers BM; Townsend CM
    Anticancer Res; 2000; 20(2A):779-84. PubMed ID: 10810354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity.
    Choi YH
    Int J Oncol; 2006 Nov; 29(5):1207-13. PubMed ID: 17016653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.
    Foglietta F; Serpe L; Canaparo R; Vivenza N; Riccio G; Imbalzano E; Gasco P; Zara GP
    J Pharm Pharm Sci; 2014; 17(2):231-47. PubMed ID: 24934552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823.
    Shi SL; Wang YY; Liang Y; Li QF
    World J Gastroenterol; 2006 Mar; 12(11):1694-8. PubMed ID: 16586536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts.
    Bernhard D; Ausserlechner MJ; Tonko M; Löffler M; Hartmann BL; Csordas A; Kofler R
    FASEB J; 1999 Nov; 13(14):1991-2001. PubMed ID: 10544182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells.
    Luo XJ; Li LL; Deng QP; Yu XF; Yang LF; Luo FJ; Xiao LB; Chen XY; Ye M; Liu JK; Cao Y
    Eur J Cancer; 2011 Jan; 47(2):316-25. PubMed ID: 20943371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
    Kim J; Park H; Im JY; Choi WS; Kim HS
    Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells.
    Tsai LC; Hung MW; Chang GG; Chang TC
    Anticancer Res; 2000; 20(4):2441-8. PubMed ID: 10953308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
    Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma.
    Zhang CZ; Chen GG; Merchant JL; Lai PB
    Cell Cycle; 2012 Jan; 11(2):322-34. PubMed ID: 22214764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.